nicotine has been researched along with levonorgestrel in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Adeyanju, OA; Areola, ED; Michael, OS; Olatunji, LA; Soladoye, AO | 1 |
Michael, OS; Olatunji, LA | 1 |
5 other study(ies) available for nicotine and levonorgestrel
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Anti-inflammatory and antithrombotic effects of nicotine exposure in oral contraceptive-induced insulin resistance are glucocorticoid-independent.
Topics: Animals; Anti-Inflammatory Agents; Blood Viscosity; Contraceptives, Oral; Corticosterone; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Fibrinolytic Agents; Glucocorticoids; Insulin Resistance; Levonorgestrel; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley | 2017 |
Ameliorative effect of nicotine exposure on insulin resistance is accompanied by decreased cardiac glycogen synthase kinase-3 and plasminogen activator inhibitor-1 during oral oestrogen-progestin therapy.
Topics: Administration, Oral; Aldosterone; Animals; Biomarkers; Cardiovascular Diseases; Contraceptives, Oral, Combined; Corticosterone; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Glycogen Synthase Kinase 3; Heart; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Levonorgestrel; Myocardium; Nicotine; Nicotinic Agonists; Plasminogen Activator Inhibitor 1; Prediabetic State; Random Allocation; Rats, Wistar | 2018 |